Antihistamines and Myelin Repair
A 2017 study published in The Lancet aimed to analyze the efficacy and safety of clemastine fumarate, an antihistamine, as a treatment for patients with multiple sclerosis. Study: Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial This study showed that a small group of patients suffering with